Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

NCT06037733 · clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
134
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hubei Cancer Hospital